Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the ...

While Lumipulse is the first FDA-approved blood test for Alzheimer’s diagnosis, other similar tests are available, but they are not yet authorized by the FDA. These include the AD-Detect Test ...

Lumipulse proved successful in a clinical trial. Before earning FDA clearance, a clinical trial tested the blood samples of 499 cognitively impaired adults to evaluate them for Alzheimer’s disease.

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans ... The FDA has approved two Alzheimer's drugs targeting amyloid plaques in adults with ...

The FDA has cleared Lumipulse, the first-ever blood test for early Alzheimer's detection, reducing the need for costly and invasive procedures.

The FDA found that the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is substantially equivalent to the Lumipulse G β-amyloid Ratio (1-42/1-40), ...

The FDA cleared Lumipulse for patients at least 55 years old with symptoms of the disease, based on a clinical study of 499 plasma samples from patients with cognitive impairment.

The FDA has approved the first blood test to detect signs of Alzheimer’s disease, marking a major step toward easier diagnosis. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test ...

Fujirebio's test works with the company's Lumipulse equipment, which the company says is already "widely available in clinical laboratories" around the U.S. Fujirebio describes Lumipulse as a ...

The Food and Drug Administration (FDA) has cleared the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio blood test for early detection of amyloid plaques associated with Alzheimer disease (AD) in ...

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s disease, the first diagnostic tool that uses a blood draw to check for ...